Commodore Capital as of Sept. 30, 2024
Portfolio Holdings for Commodore Capital
Commodore Capital holds 36 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 10.5 | $167M | 3.4M | 49.96 | |
| Vera Therapeutics Cl A (VERA) | 6.8 | $109M | 2.5M | 44.20 | |
| Xenon Pharmaceuticals (XENE) | 6.6 | $106M | 2.7M | 39.37 | |
| Vaxcyte (PCVX) | 6.6 | $105M | 920k | 114.27 | |
| Enliven Therapeutics (ELVN) | 6.5 | $105M | 4.1M | 25.54 | |
| Nuvalent Inc-a (NUVL) | 6.0 | $96M | 940k | 102.30 | |
| Cogent Biosciences (COGT) | 5.1 | $81M | 7.5M | 10.80 | |
| Alkermes SHS (ALKS) | 5.1 | $81M | 2.9M | 27.99 | |
| Soleno Therapeutics (SLNO) | 4.0 | $64M | 1.3M | 50.49 | |
| Spyre Therapeutics Com New (SYRE) | 3.7 | $59M | 2.0M | 29.41 | |
| Miragen Therapeutics (VRDN) | 3.6 | $58M | 2.6M | 22.75 | |
| Celldex Therapeutics Com New (CLDX) | 3.4 | $55M | 1.6M | 33.99 | |
| Mind Medicine Mindmed Com New (MNMD) | 2.8 | $46M | 8.0M | 5.69 | |
| Perspective Therapeutics Com New (CATX) | 2.8 | $45M | 3.4M | 13.35 | |
| Nurix Therapeutics (NRIX) | 2.3 | $37M | 1.7M | 22.47 | |
| Pharvaris N V (PHVS) | 2.2 | $35M | 1.9M | 18.52 | |
| Kura Oncology (KURA) | 2.2 | $35M | 1.8M | 19.54 | |
| Rhythm Pharmaceuticals (RYTM) | 2.1 | $34M | 650k | 52.39 | |
| Oruka Therapeutics | 2.1 | $34M | 1.4M | 24.51 | |
| Arvinas Ord (ARVN) | 1.8 | $30M | 1.2M | 24.63 | |
| Celcuity (CELC) | 1.4 | $23M | 1.5M | 14.91 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.3 | $22M | 1.4M | 15.99 | |
| Nkarta (NKTX) | 1.3 | $21M | 4.7M | 4.52 | |
| Oric Pharmaceuticals (ORIC) | 1.3 | $21M | 2.0M | 10.25 | |
| C4 Therapeutics Com Stk (CCCC) | 1.2 | $19M | 3.4M | 5.70 | |
| Third Harmonic Bio (THRD) | 1.2 | $18M | 1.4M | 13.55 | |
| Syndax Pharmaceuticals (SNDX) | 1.1 | $17M | 885k | 19.25 | |
| Apogee Therapeutics (APGE) | 1.1 | $17M | 290k | 58.74 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.9 | $15M | 1.3M | 11.52 | |
| Instil Bio Com New (TIL) | 0.6 | $10M | 151k | 67.32 | |
| Neurogene (NGNE) | 0.5 | $8.4M | 200k | 41.96 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.5 | $7.5M | 750k | 10.01 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.3 | $5.2M | 500k | 10.45 | |
| Cabaletta Bio (CABA) | 0.3 | $5.2M | 1.1M | 4.72 | |
| Vistagen Therapeutics Ord (VTGN) | 0.3 | $4.7M | 1.6M | 3.01 | |
| Avalo Therapeutics Com New (AVTX) | 0.3 | $4.6M | 483k | 9.50 |
